nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A5—Thalidomide—leprosy	0.153	0.245	CbGbCtD
Boceprevir—CYP3A5—Rifampicin—leprosy	0.148	0.237	CbGbCtD
Boceprevir—CYP3A5—Dapsone—leprosy	0.122	0.196	CbGbCtD
Boceprevir—ABCB1—Rifampicin—leprosy	0.0963	0.154	CbGbCtD
Boceprevir—CYP3A4—Rifampicin—leprosy	0.0577	0.0924	CbGbCtD
Boceprevir—CYP3A4—Dapsone—leprosy	0.0476	0.0763	CbGbCtD
Boceprevir—CTSK—hindlimb—leprosy	0.0169	0.142	CbGeAlD
Boceprevir—CTSK—appendage—leprosy	0.0145	0.122	CbGeAlD
Boceprevir—CMA1—blood vessel—leprosy	0.0125	0.105	CbGeAlD
Boceprevir—Toxic skin eruption—Thalidomide—leprosy	0.00967	0.0498	CcSEcCtD
Boceprevir—CTSV—eye—leprosy	0.00697	0.0587	CbGeAlD
Boceprevir—CTSV—skin of body—leprosy	0.00606	0.0511	CbGeAlD
Boceprevir—Mental status changes—Thalidomide—leprosy	0.00596	0.0307	CcSEcCtD
Boceprevir—CMA1—skin of body—leprosy	0.00579	0.0488	CbGeAlD
Boceprevir—CTSL—eye—leprosy	0.00569	0.048	CbGeAlD
Boceprevir—CTSL—skin of body—leprosy	0.00495	0.0417	CbGeAlD
Boceprevir—Suicide attempt—Dapsone—leprosy	0.00483	0.0249	CcSEcCtD
Boceprevir—CTSK—eye—leprosy	0.00429	0.0361	CbGeAlD
Boceprevir—CTSV—testis—leprosy	0.00382	0.0322	CbGeAlD
Boceprevir—CTSL—tendon—leprosy	0.00377	0.0318	CbGeAlD
Boceprevir—CTSV—nervous system—leprosy	0.00375	0.0316	CbGeAlD
Boceprevir—CTSK—skin of body—leprosy	0.00373	0.0314	CbGeAlD
Boceprevir—Fungal skin infection—Thalidomide—leprosy	0.00336	0.0173	CcSEcCtD
Boceprevir—CTSS—skin of body—leprosy	0.00327	0.0275	CbGeAlD
Boceprevir—Pericarditis—Thalidomide—leprosy	0.00325	0.0167	CcSEcCtD
Boceprevir—CTSL—testis—leprosy	0.00312	0.0263	CbGeAlD
Boceprevir—CTSL—nervous system—leprosy	0.00306	0.0258	CbGeAlD
Boceprevir—Aphthous stomatitis—Thalidomide—leprosy	0.00299	0.0154	CcSEcCtD
Boceprevir—Tongue discolouration—Thalidomide—leprosy	0.0029	0.015	CcSEcCtD
Boceprevir—Cerebral ischaemia—Thalidomide—leprosy	0.0029	0.015	CcSEcCtD
Boceprevir—CTSK—tendon—leprosy	0.00284	0.0239	CbGeAlD
Boceprevir—Lymphopenia—Thalidomide—leprosy	0.00274	0.0141	CcSEcCtD
Boceprevir—Venous thrombosis—Thalidomide—leprosy	0.0026	0.0134	CcSEcCtD
Boceprevir—CTSS—tendon—leprosy	0.00249	0.021	CbGeAlD
Boceprevir—Suicide attempt—Thalidomide—leprosy	0.00247	0.0127	CcSEcCtD
Boceprevir—CTSK—testis—leprosy	0.00235	0.0198	CbGeAlD
Boceprevir—CTSK—nervous system—leprosy	0.00231	0.0194	CbGeAlD
Boceprevir—Deep vein thrombosis—Thalidomide—leprosy	0.00231	0.0119	CcSEcCtD
Boceprevir—Psoriasis—Thalidomide—leprosy	0.00223	0.0115	CcSEcCtD
Boceprevir—Hypothyroidism—Thalidomide—leprosy	0.00219	0.0113	CcSEcCtD
Boceprevir—Tooth disorder—Thalidomide—leprosy	0.00216	0.0112	CcSEcCtD
Boceprevir—CTSS—testis—leprosy	0.00206	0.0174	CbGeAlD
Boceprevir—CTSS—nervous system—leprosy	0.00202	0.017	CbGeAlD
Boceprevir—Neuralgia—Thalidomide—leprosy	0.00202	0.0104	CcSEcCtD
Boceprevir—Hypercalcaemia—Thalidomide—leprosy	0.00202	0.0104	CcSEcCtD
Boceprevir—Metrorrhagia—Thalidomide—leprosy	0.00196	0.0101	CcSEcCtD
Boceprevir—Psychotic disorder—Dapsone—leprosy	0.00194	0.01	CcSEcCtD
Boceprevir—CTSV—Toll-Like Receptors Cascades—TLR2—leprosy	0.00188	0.03	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—RIPK2—leprosy	0.00188	0.03	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—RIPK2—leprosy	0.00188	0.03	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—TLR2—leprosy	0.00188	0.03	CbGpPWpGaD
Boceprevir—Skin ulcer—Thalidomide—leprosy	0.0018	0.00929	CcSEcCtD
Boceprevir—Hyperaesthesia—Thalidomide—leprosy	0.00179	0.00921	CcSEcCtD
Boceprevir—Nasopharyngitis—Dapsone—leprosy	0.00178	0.00917	CcSEcCtD
Boceprevir—Muscular weakness—Dapsone—leprosy	0.00176	0.00904	CcSEcCtD
Boceprevir—Influenza—Dapsone—leprosy	0.00172	0.00886	CcSEcCtD
Boceprevir—CTSL—Toll-Like Receptors Cascades—NOD2—leprosy	0.0017	0.0272	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—NOD2—leprosy	0.0017	0.0272	CbGpPWpGaD
Boceprevir—Endocrine disorder—Thalidomide—leprosy	0.00169	0.00872	CcSEcCtD
Boceprevir—Pancreatitis—Dapsone—leprosy	0.00169	0.00869	CcSEcCtD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—PARK2—leprosy	0.00162	0.0259	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—PARK2—leprosy	0.00162	0.0259	CbGpPWpGaD
Boceprevir—Amenorrhoea—Thalidomide—leprosy	0.0016	0.00823	CcSEcCtD
Boceprevir—Photosensitivity reaction—Dapsone—leprosy	0.00157	0.00809	CcSEcCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—RIPK2—leprosy	0.00156	0.0249	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—TLR2—leprosy	0.00156	0.0249	CbGpPWpGaD
Boceprevir—Hyperbilirubinaemia—Thalidomide—leprosy	0.00154	0.00795	CcSEcCtD
Boceprevir—Cellulitis—Thalidomide—leprosy	0.00154	0.00795	CcSEcCtD
Boceprevir—Herpes simplex—Thalidomide—leprosy	0.00152	0.00785	CcSEcCtD
Boceprevir—Hyperuricaemia—Thalidomide—leprosy	0.00151	0.0078	CcSEcCtD
Boceprevir—Neuropathy peripheral—Dapsone—leprosy	0.0015	0.00775	CcSEcCtD
Boceprevir—CTSV—MHC class II antigen presentation—HLA-DRB1—leprosy	0.0015	0.024	CbGpPWpGaD
Boceprevir—CTSL—MHC class II antigen presentation—HLA-DRB1—leprosy	0.0015	0.024	CbGpPWpGaD
Boceprevir—Hearing impaired—Thalidomide—leprosy	0.00147	0.0076	CcSEcCtD
Boceprevir—Bone pain—Thalidomide—leprosy	0.00147	0.00755	CcSEcCtD
Boceprevir—Sinusitis—Dapsone—leprosy	0.00144	0.00741	CcSEcCtD
Boceprevir—Blood uric acid increased—Thalidomide—leprosy	0.00143	0.00736	CcSEcCtD
Boceprevir—Neck pain—Thalidomide—leprosy	0.00142	0.00732	CcSEcCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—NOD2—leprosy	0.00141	0.0225	CbGpPWpGaD
Boceprevir—Pulmonary embolism—Thalidomide—leprosy	0.0014	0.00723	CcSEcCtD
Boceprevir—Pharyngitis—Dapsone—leprosy	0.00137	0.00704	CcSEcCtD
Boceprevir—Colitis—Thalidomide—leprosy	0.00135	0.00694	CcSEcCtD
Boceprevir—Candida infection—Thalidomide—leprosy	0.00134	0.0069	CcSEcCtD
Boceprevir—Dry eye—Thalidomide—leprosy	0.0013	0.00668	CcSEcCtD
Boceprevir—Tinnitus—Dapsone—leprosy	0.00128	0.00661	CcSEcCtD
Boceprevir—CTSS—Toll-Like Receptors Cascades—RIPK2—leprosy	0.00128	0.0205	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—TLR2—leprosy	0.00128	0.0205	CbGpPWpGaD
Boceprevir—Rash maculo-papular—Thalidomide—leprosy	0.00128	0.00657	CcSEcCtD
Boceprevir—ABCB1—blood vessel—leprosy	0.00125	0.0105	CbGeAlD
Boceprevir—CTSK—MHC class II antigen presentation—HLA-DRB1—leprosy	0.00124	0.0199	CbGpPWpGaD
Boceprevir—Sepsis—Thalidomide—leprosy	0.00122	0.00628	CcSEcCtD
Boceprevir—Mental disability—Thalidomide—leprosy	0.00122	0.00628	CcSEcCtD
Boceprevir—Erythema—Dapsone—leprosy	0.0012	0.00618	CcSEcCtD
Boceprevir—Lymphadenopathy—Thalidomide—leprosy	0.00119	0.00615	CcSEcCtD
Boceprevir—Diabetes mellitus—Thalidomide—leprosy	0.00117	0.00604	CcSEcCtD
Boceprevir—CTSS—Toll-Like Receptors Cascades—NOD2—leprosy	0.00116	0.0186	CbGpPWpGaD
Boceprevir—Gastroenteritis—Thalidomide—leprosy	0.00115	0.00592	CcSEcCtD
Boceprevir—Deafness—Thalidomide—leprosy	0.00114	0.00587	CcSEcCtD
Boceprevir—Eczema—Thalidomide—leprosy	0.00113	0.00584	CcSEcCtD
Boceprevir—Vision blurred—Dapsone—leprosy	0.00113	0.00582	CcSEcCtD
Boceprevir—Eye pain—Thalidomide—leprosy	0.00113	0.00582	CcSEcCtD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—PARK2—leprosy	0.0011	0.0176	CbGpPWpGaD
Boceprevir—Amnesia—Thalidomide—leprosy	0.00108	0.00559	CcSEcCtD
Boceprevir—Dermatitis exfoliative—Thalidomide—leprosy	0.00108	0.00556	CcSEcCtD
Boceprevir—Vertigo—Dapsone—leprosy	0.00108	0.00555	CcSEcCtD
Boceprevir—Atrial fibrillation—Thalidomide—leprosy	0.00108	0.00554	CcSEcCtD
Boceprevir—Arthritis—Thalidomide—leprosy	0.00105	0.0054	CcSEcCtD
Boceprevir—Cough—Dapsone—leprosy	0.00105	0.00539	CcSEcCtD
Boceprevir—Lethargy—Thalidomide—leprosy	0.00104	0.00536	CcSEcCtD
Boceprevir—CTSS—MHC class II antigen presentation—HLA-DRB1—leprosy	0.00102	0.0164	CbGpPWpGaD
Boceprevir—Pain in extremity—Thalidomide—leprosy	0.00102	0.00525	CcSEcCtD
Boceprevir—Affect lability—Thalidomide—leprosy	0.001	0.00517	CcSEcCtD
Boceprevir—Migraine—Thalidomide—leprosy	0.001	0.00517	CcSEcCtD
Boceprevir—Psychotic disorder—Thalidomide—leprosy	0.000995	0.00513	CcSEcCtD
Boceprevir—Mood swings—Thalidomide—leprosy	0.000965	0.00497	CcSEcCtD
Boceprevir—Tachycardia—Dapsone—leprosy	0.000955	0.00492	CcSEcCtD
Boceprevir—Dehydration—Thalidomide—leprosy	0.000947	0.00488	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CYLD—leprosy	0.000943	0.0151	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CYLD—leprosy	0.000943	0.0151	CbGpPWpGaD
Boceprevir—Dry skin—Thalidomide—leprosy	0.000934	0.00481	CcSEcCtD
Boceprevir—Hypokalaemia—Thalidomide—leprosy	0.000927	0.00478	CcSEcCtD
Boceprevir—Breast disorder—Thalidomide—leprosy	0.000921	0.00474	CcSEcCtD
Boceprevir—Muscular weakness—Thalidomide—leprosy	0.000899	0.00463	CcSEcCtD
Boceprevir—Abdominal distension—Thalidomide—leprosy	0.000886	0.00457	CcSEcCtD
Boceprevir—Insomnia—Dapsone—leprosy	0.000885	0.00456	CcSEcCtD
Boceprevir—Influenza—Thalidomide—leprosy	0.000881	0.00454	CcSEcCtD
Boceprevir—Dysphagia—Thalidomide—leprosy	0.000881	0.00454	CcSEcCtD
Boceprevir—Eosinophilia—Thalidomide—leprosy	0.000872	0.00449	CcSEcCtD
Boceprevir—Pancreatitis—Thalidomide—leprosy	0.000863	0.00445	CcSEcCtD
Boceprevir—Bronchitis—Thalidomide—leprosy	0.000847	0.00436	CcSEcCtD
Boceprevir—Pancytopenia—Thalidomide—leprosy	0.000836	0.00431	CcSEcCtD
Boceprevir—Neutropenia—Thalidomide—leprosy	0.000823	0.00424	CcSEcCtD
Boceprevir—Pollakiuria—Thalidomide—leprosy	0.000813	0.00419	CcSEcCtD
Boceprevir—Erectile dysfunction—Thalidomide—leprosy	0.000811	0.00418	CcSEcCtD
Boceprevir—Photosensitivity reaction—Thalidomide—leprosy	0.000804	0.00414	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—PARK2—leprosy	0.000801	0.0128	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PARK2—leprosy	0.000801	0.0128	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Dapsone—leprosy	0.0008	0.00412	CcSEcCtD
Boceprevir—Weight decreased—Thalidomide—leprosy	0.000797	0.00411	CcSEcCtD
Boceprevir—Hyperglycaemia—Thalidomide—leprosy	0.000794	0.00409	CcSEcCtD
Boceprevir—Pneumonia—Thalidomide—leprosy	0.00079	0.00407	CcSEcCtD
Boceprevir—Infestation—Thalidomide—leprosy	0.000785	0.00405	CcSEcCtD
Boceprevir—Infestation NOS—Thalidomide—leprosy	0.000785	0.00405	CcSEcCtD
Boceprevir—Depression—Thalidomide—leprosy	0.000783	0.00403	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CYLD—leprosy	0.000782	0.0125	CbGpPWpGaD
Boceprevir—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000778	0.00401	CcSEcCtD
Boceprevir—Abdominal pain—Dapsone—leprosy	0.000773	0.00398	CcSEcCtD
Boceprevir—Body temperature increased—Dapsone—leprosy	0.000773	0.00398	CcSEcCtD
Boceprevir—Neuropathy peripheral—Thalidomide—leprosy	0.00077	0.00397	CcSEcCtD
Boceprevir—Stomatitis—Thalidomide—leprosy	0.000765	0.00394	CcSEcCtD
Boceprevir—Conjunctivitis—Thalidomide—leprosy	0.000763	0.00393	CcSEcCtD
Boceprevir—Epistaxis—Thalidomide—leprosy	0.000741	0.00382	CcSEcCtD
Boceprevir—Sinusitis—Thalidomide—leprosy	0.000737	0.0038	CcSEcCtD
Boceprevir—Agranulocytosis—Thalidomide—leprosy	0.000733	0.00378	CcSEcCtD
Boceprevir—Rhinitis—Thalidomide—leprosy	0.000707	0.00364	CcSEcCtD
Boceprevir—Hypoaesthesia—Thalidomide—leprosy	0.000701	0.00361	CcSEcCtD
Boceprevir—Pharyngitis—Thalidomide—leprosy	0.0007	0.0036	CcSEcCtD
Boceprevir—Urinary tract disorder—Thalidomide—leprosy	0.000696	0.00359	CcSEcCtD
Boceprevir—Oedema peripheral—Thalidomide—leprosy	0.000694	0.00358	CcSEcCtD
Boceprevir—Urethral disorder—Thalidomide—leprosy	0.000691	0.00356	CcSEcCtD
Boceprevir—Visual impairment—Thalidomide—leprosy	0.000679	0.0035	CcSEcCtD
Boceprevir—Erythema multiforme—Thalidomide—leprosy	0.000666	0.00343	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—PARK2—leprosy	0.000664	0.0106	CbGpPWpGaD
Boceprevir—Eye disorder—Thalidomide—leprosy	0.000659	0.00339	CcSEcCtD
Boceprevir—Tinnitus—Thalidomide—leprosy	0.000657	0.00339	CcSEcCtD
Boceprevir—Cardiac disorder—Thalidomide—leprosy	0.000654	0.00337	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CYLD—leprosy	0.000644	0.0103	CbGpPWpGaD
Boceprevir—Angiopathy—Thalidomide—leprosy	0.000639	0.0033	CcSEcCtD
Boceprevir—Immune system disorder—Thalidomide—leprosy	0.000637	0.00328	CcSEcCtD
Boceprevir—Mediastinal disorder—Thalidomide—leprosy	0.000635	0.00327	CcSEcCtD
Boceprevir—Chills—Thalidomide—leprosy	0.000632	0.00326	CcSEcCtD
Boceprevir—Arrhythmia—Thalidomide—leprosy	0.00063	0.00324	CcSEcCtD
Boceprevir—Alopecia—Thalidomide—leprosy	0.000623	0.00321	CcSEcCtD
Boceprevir—Vomiting—Dapsone—leprosy	0.000622	0.0032	CcSEcCtD
Boceprevir—Mental disorder—Thalidomide—leprosy	0.000617	0.00318	CcSEcCtD
Boceprevir—Malnutrition—Thalidomide—leprosy	0.000614	0.00316	CcSEcCtD
Boceprevir—Headache—Dapsone—leprosy	0.000613	0.00316	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—RIPK2—leprosy	0.000608	0.00972	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—RIPK2—leprosy	0.000608	0.00972	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TLR2—leprosy	0.000608	0.00972	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TLR2—leprosy	0.000608	0.00972	CbGpPWpGaD
Boceprevir—Flatulence—Thalidomide—leprosy	0.000605	0.00312	CcSEcCtD
Boceprevir—Dysgeusia—Thalidomide—leprosy	0.000601	0.0031	CcSEcCtD
Boceprevir—Back pain—Thalidomide—leprosy	0.000593	0.00306	CcSEcCtD
Boceprevir—Muscle spasms—Thalidomide—leprosy	0.00059	0.00304	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—RIPK2—leprosy	0.000584	0.00933	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—RIPK2—leprosy	0.000584	0.00933	CbGpPWpGaD
Boceprevir—Nausea—Dapsone—leprosy	0.000581	0.00299	CcSEcCtD
Boceprevir—Vision blurred—Thalidomide—leprosy	0.000578	0.00298	CcSEcCtD
Boceprevir—Ill-defined disorder—Thalidomide—leprosy	0.000569	0.00293	CcSEcCtD
Boceprevir—Anaemia—Thalidomide—leprosy	0.000567	0.00292	CcSEcCtD
Boceprevir—Agitation—Thalidomide—leprosy	0.000564	0.00291	CcSEcCtD
Boceprevir—Angioedema—Thalidomide—leprosy	0.000561	0.00289	CcSEcCtD
Boceprevir—Malaise—Thalidomide—leprosy	0.000553	0.00285	CcSEcCtD
Boceprevir—Vertigo—Thalidomide—leprosy	0.000551	0.00284	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—NOD2—leprosy	0.000551	0.00881	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NOD2—leprosy	0.000551	0.00881	CbGpPWpGaD
Boceprevir—Syncope—Thalidomide—leprosy	0.00055	0.00284	CcSEcCtD
Boceprevir—CTSL—Immune System—CYLD—leprosy	0.000549	0.00878	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CYLD—leprosy	0.000549	0.00878	CbGpPWpGaD
Boceprevir—Leukopenia—Thalidomide—leprosy	0.000549	0.00283	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PARK2—leprosy	0.000546	0.00873	CbGpPWpGaD
Boceprevir—Palpitations—Thalidomide—leprosy	0.000542	0.00279	CcSEcCtD
Boceprevir—Loss of consciousness—Thalidomide—leprosy	0.000539	0.00278	CcSEcCtD
Boceprevir—Cough—Thalidomide—leprosy	0.000535	0.00276	CcSEcCtD
Boceprevir—Hypertension—Thalidomide—leprosy	0.00053	0.00273	CcSEcCtD
Boceprevir—Arthralgia—Thalidomide—leprosy	0.000522	0.00269	CcSEcCtD
Boceprevir—Myalgia—Thalidomide—leprosy	0.000522	0.00269	CcSEcCtD
Boceprevir—Chest pain—Thalidomide—leprosy	0.000522	0.00269	CcSEcCtD
Boceprevir—Anxiety—Thalidomide—leprosy	0.000521	0.00268	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000519	0.00267	CcSEcCtD
Boceprevir—Discomfort—Thalidomide—leprosy	0.000516	0.00266	CcSEcCtD
Boceprevir—Dry mouth—Thalidomide—leprosy	0.000511	0.00263	CcSEcCtD
Boceprevir—Confusional state—Thalidomide—leprosy	0.000505	0.0026	CcSEcCtD
Boceprevir—CYP3A4—nervous system—leprosy	0.000504	0.00425	CbGeAlD
Boceprevir—CTSK—Innate Immune System—RIPK2—leprosy	0.000504	0.00805	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR2—leprosy	0.000504	0.00805	CbGpPWpGaD
Boceprevir—Infection—Thalidomide—leprosy	0.000497	0.00256	CcSEcCtD
Boceprevir—Shock—Thalidomide—leprosy	0.000493	0.00254	CcSEcCtD
Boceprevir—Nervous system disorder—Thalidomide—leprosy	0.000491	0.00253	CcSEcCtD
Boceprevir—Thrombocytopenia—Thalidomide—leprosy	0.00049	0.00253	CcSEcCtD
Boceprevir—Tachycardia—Thalidomide—leprosy	0.000489	0.00252	CcSEcCtD
Boceprevir—Skin disorder—Thalidomide—leprosy	0.000486	0.00251	CcSEcCtD
Boceprevir—CTSL—Immune System—PARK2—leprosy	0.000486	0.00776	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PARK2—leprosy	0.000486	0.00776	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Thalidomide—leprosy	0.000484	0.00249	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—RIPK2—leprosy	0.000484	0.00773	CbGpPWpGaD
Boceprevir—Hypotension—Thalidomide—leprosy	0.000468	0.00241	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—NOD2—leprosy	0.000457	0.0073	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Thalidomide—leprosy	0.000456	0.00235	CcSEcCtD
Boceprevir—CTSK—Immune System—CYLD—leprosy	0.000455	0.00728	CbGpPWpGaD
Boceprevir—Insomnia—Thalidomide—leprosy	0.000453	0.00233	CcSEcCtD
Boceprevir—Paraesthesia—Thalidomide—leprosy	0.00045	0.00232	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—CD40LG—leprosy	0.000447	0.00715	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD40LG—leprosy	0.000447	0.00715	CbGpPWpGaD
Boceprevir—Dyspnoea—Thalidomide—leprosy	0.000446	0.0023	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—CD8A—leprosy	0.000442	0.00707	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD8A—leprosy	0.000442	0.00707	CbGpPWpGaD
Boceprevir—Dyspepsia—Thalidomide—leprosy	0.000441	0.00227	CcSEcCtD
Boceprevir—Decreased appetite—Thalidomide—leprosy	0.000435	0.00224	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Thalidomide—leprosy	0.000432	0.00223	CcSEcCtD
Boceprevir—Fatigue—Thalidomide—leprosy	0.000432	0.00222	CcSEcCtD
Boceprevir—Pain—Thalidomide—leprosy	0.000428	0.00221	CcSEcCtD
Boceprevir—Constipation—Thalidomide—leprosy	0.000428	0.00221	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—TLR2—leprosy	0.000415	0.00663	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—RIPK2—leprosy	0.000415	0.00663	CbGpPWpGaD
Boceprevir—Feeling abnormal—Thalidomide—leprosy	0.000413	0.00213	CcSEcCtD
Boceprevir—Gastrointestinal pain—Thalidomide—leprosy	0.000409	0.00211	CcSEcCtD
Boceprevir—CTSK—Immune System—PARK2—leprosy	0.000402	0.00643	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—RIPK2—leprosy	0.000398	0.00637	CbGpPWpGaD
Boceprevir—Urticaria—Thalidomide—leprosy	0.000398	0.00205	CcSEcCtD
Boceprevir—Body temperature increased—Thalidomide—leprosy	0.000396	0.00204	CcSEcCtD
Boceprevir—Abdominal pain—Thalidomide—leprosy	0.000396	0.00204	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—NOD2—leprosy	0.000376	0.00601	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CYLD—leprosy	0.000375	0.00599	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD40LG—leprosy	0.000371	0.00593	CbGpPWpGaD
Boceprevir—Hypersensitivity—Thalidomide—leprosy	0.000369	0.0019	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CD8A—leprosy	0.000367	0.00586	CbGpPWpGaD
Boceprevir—ABCB1—testis—leprosy	0.000364	0.00306	CbGeAlD
Boceprevir—CTSV—Adaptive Immune System—HLA-DRB1—leprosy	0.00036	0.00576	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HLA-DRB1—leprosy	0.00036	0.00576	CbGpPWpGaD
Boceprevir—Asthenia—Thalidomide—leprosy	0.000359	0.00185	CcSEcCtD
Boceprevir—ABCB1—nervous system—leprosy	0.000357	0.00301	CbGeAlD
Boceprevir—Pruritus—Thalidomide—leprosy	0.000354	0.00183	CcSEcCtD
Boceprevir—CTSV—Immune System—RIPK2—leprosy	0.000354	0.00566	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RIPK2—leprosy	0.000354	0.00566	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR2—leprosy	0.000354	0.00566	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TLR2—leprosy	0.000354	0.00566	CbGpPWpGaD
Boceprevir—Diarrhoea—Thalidomide—leprosy	0.000343	0.00177	CcSEcCtD
Boceprevir—CTSS—Immune System—PARK2—leprosy	0.000331	0.0053	CbGpPWpGaD
Boceprevir—Dizziness—Thalidomide—leprosy	0.000331	0.00171	CcSEcCtD
Boceprevir—CTSL—Immune System—NOD2—leprosy	0.000321	0.00513	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NOD2—leprosy	0.000321	0.00513	CbGpPWpGaD
Boceprevir—Vomiting—Thalidomide—leprosy	0.000318	0.00164	CcSEcCtD
Boceprevir—Rash—Thalidomide—leprosy	0.000316	0.00163	CcSEcCtD
Boceprevir—Dermatitis—Thalidomide—leprosy	0.000315	0.00163	CcSEcCtD
Boceprevir—Headache—Thalidomide—leprosy	0.000314	0.00162	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD40LG—leprosy	0.000305	0.00488	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD8A—leprosy	0.000302	0.00482	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HLA-DRB1—leprosy	0.000298	0.00477	CbGpPWpGaD
Boceprevir—Nausea—Thalidomide—leprosy	0.000297	0.00153	CcSEcCtD
Boceprevir—CTSK—Immune System—RIPK2—leprosy	0.000293	0.00469	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TLR2—leprosy	0.000293	0.00469	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD40LG—leprosy	0.000271	0.00434	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD40LG—leprosy	0.000271	0.00434	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD8A—leprosy	0.000268	0.00429	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD8A—leprosy	0.000268	0.00429	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NOD2—leprosy	0.000266	0.00425	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CD4—leprosy	0.000265	0.00423	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD4—leprosy	0.000265	0.00423	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CD40LG—leprosy	0.000257	0.00411	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL10—leprosy	0.000257	0.00411	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD4—leprosy	0.000254	0.00406	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD4—leprosy	0.000254	0.00406	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-DRB1—leprosy	0.000246	0.00393	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RIPK2—leprosy	0.000242	0.00386	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TLR2—leprosy	0.000242	0.00386	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD40LG—leprosy	0.000225	0.00359	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD8A—leprosy	0.000222	0.00355	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD4—leprosy	0.000219	0.0035	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NOD2—leprosy	0.000219	0.0035	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-DRB1—leprosy	0.000218	0.00349	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-DRB1—leprosy	0.000218	0.00349	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RIPK2—leprosy	0.000213	0.0034	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD4—leprosy	0.000211	0.00337	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	0.000207	0.00331	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD40LG—leprosy	0.000185	0.00296	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD8A—leprosy	0.000183	0.00293	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-DRB1—leprosy	0.000181	0.00289	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CD4—leprosy	0.000181	0.00289	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD4—leprosy	0.000173	0.00277	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNG—leprosy	0.00016	0.00255	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFNG—leprosy	0.00016	0.00255	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD4—leprosy	0.000154	0.00246	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD4—leprosy	0.000154	0.00246	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IFNG—leprosy	0.000151	0.00242	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-DRB1—leprosy	0.000149	0.00238	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—leprosy	0.000142	0.00227	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—leprosy	0.000142	0.00227	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2—leprosy	0.000134	0.00215	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNG—leprosy	0.000132	0.00211	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD4—leprosy	0.000128	0.00204	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—leprosy	0.000117	0.00188	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNG—leprosy	0.000109	0.00174	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD4—leprosy	0.000105	0.00168	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—leprosy	9.79e-05	0.00156	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—leprosy	9.68e-05	0.00155	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	9.02e-05	0.00144	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—leprosy	8.52e-05	0.00136	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SDHD—leprosy	7.45e-05	0.00119	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SDHD—leprosy	5.62e-05	0.000898	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	4.83e-05	0.000772	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SDHD—leprosy	3.46e-05	0.000553	CbGpPWpGaD
